Do you need a full overview of your market access opportunities?
In smaller biotech companies it can be important to get an overview of which steps to take, and when to take them.
Pharma Evidence will build a tailored roadmap advising on which choices to take, and at what point, in relation to clinical trials, launch, pricing negations, etc.
In the basic form the Market Access Road Map: €7400.
Table of content:
- Phase II.
- Phase III.